Lymphoma: all 5,624 studies
Page 44 of 57. Open to participants first (824), then studies with results posted, then the rest; newest registration first within each.
- R Retreatment in 1st Relapsed DLBCLStatus unknownNCT00980304Phase 2
- Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or LymphomaCompletedNCT00978523Phase 1
- Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin LymphomaStatus unknownNCT00974792Phase 2
- Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell LymphomaStatus unknownNCT00974324Phase 2
- Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood DisordersTerminatedNCT00973804Phase 1
- Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)TerminatedNCT00972842Phase 1/2
- Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell LymphomaCompletedNCT00971763Phase 2
- Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell LymphomaCompletedNCT00970385Phase 3
- Doxorubicin Pharmacokinetics and Response in Non Hodgkin's LymphomaCompletedNCT00969462Phase 4
- Trial of Curcumin in Cutaneous T-cell Lymphoma PatientsWithdrawnNCT00969085Phase 2
- CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid MalignanciesCompletedNCT00968760Phase 1
- Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)TerminatedNCT00968331Phase 2
- High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell LymphomaCompletedNCT00965289Phase 2
- Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell TransplantCompletedNCT00964821
- Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.CompletedNCT00963534Phase 1/2
- Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyTerminatedNCT00963495Phase 1
- Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT00963274Phase 1
- Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaCompletedNCT00962507Phase 1
- Bendamustine in Patients With Refractory or Relapsed T-cell LymphomaCompletedNCT00959686Phase 2
- Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell LymphomaStatus unknownNCT00958854Phase 2
- Quality of Life in Younger Leukemia and Lymphoma SurvivorsCompletedNCT00956475
- Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or LymphomasCompletedNCT00955786Phase 1
- Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or LymphomasTerminatedNCT00955292Phase 1
- Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent LymphomaTerminatedNCT00954005Phase 1/2
- Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersTerminatedNCT00952185Not applicable
- A Standardized Nursing Intervention Protocol for HCT PatientsCompletedNCT00951626Not applicable
- Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma PatientsCompletedNCT00949741
- Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or LymphomaCompletedNCT00947739Phase 1
- Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)TerminatedNCT00947388Phase 1
- Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-LymphomaStatus unknownNCT00946374Phase 2
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeTerminatedNCT00946283Not applicable
- Assessing the Effectiveness of Individual Education Plans for Childhood Cancer SurvivorsCompletedNCT00945828Not applicable
- Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)CompletedNCT00944905Phase 1
- A Clinico-Pathologic Study of Primary Mediastinal B-Cell LymphomaCompletedNCT00944567
- PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin LymphomaActive, not recruitingNCT00943423Phase 3
- Temsirolimus in Recurrent Primary Central Nervous System (CNS) LymphomaStatus unknownNCT00942747Phase 2
- Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple MyelomaCompletedNCT00937183Not applicable
- Study of TAK-901 in Adults With Advanced Solid Tumors or LymphomaCompletedNCT00935844Phase 1
- Host Dendritic Cells in Allograft PatientsStatus unknownNCT00935597Phase 1
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerActive, not recruitingNCT00935090
- Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaTerminatedNCT00933985Phase 1
- New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell LymphomaStatus unknownNCT00933673Phase 2
- S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and PrednisoneCompletedNCT00933127
- Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma PatientsStatus unknownNCT00931229Not applicable
- The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)CompletedNCT00930605Phase 2
- A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular LymphomaCompletedNCT00930514Phase 1
- Breathing Adapted Radiotherapy for Mediastinal LymphomaCompletedNCT00928096
- Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)Status unknownNCT00927797Phase 2
- Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis BCompletedNCT00926757Phase 4
- Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) TypeStatus unknownNCT00923663Phase 2
- A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced MalignanciesCompletedNCT00923520Phase 1
- Mantel Cell Lymphoma Efficacy of Rituximab MaintenanceCompletedNCT00921414Phase 3
- Metabolic Syndrome in Childhood Cancer SurvivorsCompletedNCT00920738
- Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin LymphomaTerminatedNCT00920153Phase 3
- Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)CompletedNCT00916630Phase 1
- Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular LymphomaCompletedNCT00915096
- Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin LymphomaStatus unknownNCT00908180Phase 2
- Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell LymphomaStatus unknownNCT00907348Phase 2
- Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin LymphomaStatus unknownNCT00907036Phase 2
- Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell LymphomaTerminatedNCT00906841Phase 2
- Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's LymphomaCompletedNCT00903890
- IMPACT Non Hodgkins Lymphoma (NHL) StudyCompletedNCT00903812
- Zevalin Twice in Aggressive Non-Hodgkin LymphomaTerminatedNCT00902525Phase 2
- Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab EraCompletedNCT00902434
- Lenalidomide and R-CHOP in B-cell LymphomaCompletedNCT00901615Phase 1/2
- Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell LymphomaCompletedNCT00901147Phase 2
- Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory LymphomaCompletedNCT00901069Phase 1
- SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's LymphomaCompletedNCT00900484
- Collecting and Storing Biological Samples From Young Patients With Hodgkin?s LymphomaCompletedNCT00900250
- Collecting and Storing Blood Samples From Patients With CancerWithdrawnNCT00900120
- Blood Samples From Patients on a Clinical Trial to CINV During HSCTTerminatedNCT00900068
- Studying Fentanyl in Patients With CancerTerminatedNCT00899951
- Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070JCompletedNCT00899015
- Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496CompletedNCT00898963
- SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical TrialCompletedNCT00898872
- Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWithdrawnNCT00898612
- Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494CompletedNCT00898157
- Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's LymphomaCompletedNCT00897923
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical TrialCompletedNCT00897767
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaCompletedNCT00897325
- S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911CompletedNCT00896922
- Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202CompletedNCT00896662
- GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin LymphomaStatus unknownNCT00896519Phase 2
- GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin LymphomaStatus unknownNCT00893477Phase 2
- Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?CompletedNCT00892502Not applicable
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyCompletedNCT00891137Phase 1
- Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT00891072Phase 1
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- Tumor Registry of Lymphatic NeoplasiaCompletedNCT00889798
- DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or LymphomaCompletedNCT00889408Phase 1
- Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell TransplantationCompletedNCT00889278
- Positron Emission Tomography(PET) in Lymphoma AssessmentCompletedNCT00887718Not applicable
- Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and NeutropeniaWithdrawnNCT00886496Phase 1
- Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological ParametersStatus unknownNCT00882011
- Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALLActive, not recruitingNCT00881920Phase 1
- Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to TreatmentWithdrawnNCT00881387Phase 2
- Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell LymphomaTerminatedNCT00880867Phase 1
- Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell TransplantCompletedNCT00880815Phase 1
- Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or RefractoryTerminatedNCT00879528
- Early Chemotherapy Intensification in Interim-Positron Emission Tomography (PET) Positive Hodgkin LymphomaStatus unknownNCT00877747